Ann Baker and John Cole are speaking on this topic. This webinar will examine the motivations for collaboration between biopharma and academia – two different worlds. Crucially, we will also reflect on why the outcomes of such collaborations often disappoint and consider some of the interventions that both parties can make to ensure a successful outcome. We will look at how to bridge the gap between academia and biopharma.
For more information on this event, click here.
TrumpRx: Enabling direct-to-patient care?
As of December 11, 2025, a variety of manufacturers have reached agreements or stated their intent to offer discounted prices for some of their medications...